FGF2 and central nervous system cancer: Consistently, we found that recombinant human FGF2 (rhFGF2) treatment promoted the proliferation (Fig. 5B, C) and DNA repair of glioma cells but inhibited apoptosis after radiation (Fig. 5D), similar to the effects of YAP.